Advertisement

Tumor Radioimmunodetection by anti-Melanoma and anti-CEA Monoclonal Antibodies: Pilot and Prospective Studies

  • Gian Luigi Buraggi
Part of the NATO ASI Series book series (NSSA, volume 152)

Abstract

In our opinion, a logical sequence of experiments to be performed to verify whether an antigen-antibody system is suitable for clinical radioimmunodetection applications includes the following studies: pilot, multicenter and prospective trials.

Keywords

Single Photon Emission Compute Tomography Colorectal Carcinoma Single Photon Emission Compute Tomography Image Administer Activity Melanoma Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    G. L. Buraggi, Radioimmunodetection of cancer, J. Nucl. Med. All. Sci. 29:261 (1985).Google Scholar
  2. 2.
    D. M. Goldenberg, F. DeLand, E. Kim, S. Bennet, F. J. Primus, J. R. Van Nagell, N. Estes, P. De Simone, P. Rayburn, Use of radiolabeled antibodies of CEA for the detection and localization of diverse cancers by external photoscanning, N, Engl. J. Med. 298:1384 (1978).CrossRefGoogle Scholar
  3. 3.
    J. P. Mach, F. Buchegger, M. Forni, J. Ritschard, C. Berche, J. D. Lumbroso, M. Screyer, C. Giraradet, R. S. Accolla, and S. Carrel, Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy, Immunol. Today 2:239 (1981).CrossRefGoogle Scholar
  4. 4.
    S. M. Larson, J. P. Brown, P. W. Wright, J. A. Carrasquillo, I. Hellstrom, and K. E. Hellstrom, Imaging of melanoma with I-131 labeled monoclonal antibodies, J. Nucl. Med. 24:123 (1982).Google Scholar
  5. 5.
    P. Giacomini, F. Veglia, P. Cordiali Fei, T. Rehle, P. G. Natali, and S. Ferrone, Level of a membrane-bound high molecular melanoma-associated antigen and a cytoplasmic melanoma associated antigen in surgically removed tissues and in sera from patients with melanoma, Cancer Res. 44:1281 (1984).PubMedGoogle Scholar
  6. 6.
    K. Imai, P. G. Natali, N. E. Kay, B. S. Wilson, and S. Ferrone, Tissue distribution and molecular profile of a differentiation antigen detected by a monoclonal antibody (345.134S) produced against human melanoma cells, Cancer Immunol. Immuniother. 12:159 (1982).Google Scholar
  7. 7.
    K. Imai, B. S. Wilson, A. Bigotti, P. G. Natali, and S. Ferrone, A 94,000 dalton glycoprotein expressed by human melanoma and carcinoma cells, J. Natl. Cancer Inst. 68:761 (1982).PubMedGoogle Scholar
  8. 8.
    P. G. Natali, B. S. Wilson, K. Imai, A. Bigotti, and S. Ferrone, Tissue distribution, molecular profile and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells, Cancer Res. 42:583 (1982).PubMedGoogle Scholar
  9. 9.
    S. Ferrone, P. Giacomini, P. G. Natali, D. Ruiter, G. L. Buraggi, L. Callegaro, U. Rosa, A human high molecular weight-melanoma associated antigen (HMWMAA) defined by monoclonal antibodies, First Int. Meeting on Boron Neutron Capture MIT Boston, 12–14 October 1983, 174 (1983).Google Scholar
  10. 10.
    P. G. Natali, R. Cavaliere, M. Matsui, G. L. Buraggi, L. Callegaro, S. Ferrone, Human melanoma associated antigens identified with monoclonal antibodies: characterization and potential clinical application, in: “Cutaneous melanoma and precursor lesions,” D. J. Ruiter, K. Welvaart, S. Ferrone eds., M. Nijhoff, Boston (1984).Google Scholar
  11. 11.
    G. L. Buraggi, L. Callegaro, S. Ferrone, A. Turrin, N. Cascinelli, A. Attili, E. Bombardieri, G. Mariani, G. Deleide, In vivo immunodiagnosis with radiolabeled anti-melanoma antibodies and F(ab’)2 fragments, Nuclear medizin: Proeedings of the 21 Int. Ann. Meet. SNME Ulm 13–16 Sept. 1983, Schattauer Stuttgart, 713 (1983).Google Scholar
  12. 12.
    G. L. Buraggi, L. Callegaro, G. Mariani, A. Turrin, N. Cascinelli, A. Attili, E. Bombardieri, G. Terno, G. Plassio, M. Dovis, N. Mazzucca, P. G. Natali, G. A. Scassellati, U. Rosa, S. Ferrone, Imaging with 131I-labelled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab’)2 fragments, Cancer Res. 45:3378 (1985).PubMedGoogle Scholar
  13. 13.
    G. L. Buraggi, L. Callegaro, A. Turrin, N. Cascinelli, A. Attili, H. Emmanuelli, M. Gasparini, G. Deleide, G. Plassio, M. Dovis, G. Mariani, P. G. Natali, G. A. Scassellati, U. Rosa, S. Ferrone, Immunoscintigraphy with 123I, 99mTc and 111In-labelled F(ab’)2 fragments of monoclonal antibodies to a human high molecular weight-melanoma associated antigen, J. Nucl. Med. All. Sci. 28:283 (1984).Google Scholar
  14. 14.
    G. L. Buraggi, A. Turrin, N. Casccinelli, A. Attili, G. Terno, E. Bombardieri, M. Gasparini, E. Seregni, Immunoscintigraphy with antimelanoma monoclonal antibodies, in: “Tumor Immunoscintigraphy,” K. E. Britton, L. Donato eds., Gordon and Breach, London, New York (1986).Google Scholar
  15. 15.
    G. L. Buraggi, L. Callegaro, N. Cascinelli, S. Ferrone, A. Turrin, A. Attili, E. Bombardieri, M. Gasparini, G. Deleide, G. A. Scassellati, E. Seregni, Radioimmunodetection of malignant melanoma with radiolabeled (131I, 123I, 111In, 99mTc) monoclonal antibodies and F(ab’)2 fragments, in: “Nuclear Medicine in Clinical Oncology,” C. Winkler ed., Springer Verlag, Berlin Heidelberg (1986).Google Scholar
  16. 16.
    G. L. Buraggi, L. Callegaro, A. Turrin, L. Gennari, E. Bombardieri, M. Gasparini, G. Mariani, R. Doci, E. Regalia, E. Seregni, Immunoscintigraphy of colorectal carcinoma: remarks about an ongoing clinical trial; in: “Nuclear Medicine in Research and Practice,” H. Schmidt, Vauramo eds., Schattauer Verlag, Stuttgart (1984).Google Scholar
  17. 17.
    G. L. Buraggi, L. Callegaro, A. Turrin, L. Gennari, E. Bombardieri, G. Mariani, G. Deleide, M. Dovis, M. Gasparini, R. Doci, E. Regalia, E. Seregni, G. A. Scassellati, Immunoscintigraphy of colorectal carcinoma with F(ab’)2 fragments of anti-CEA monoclonal antibody, Cancer Pet. Prev. (in press).Google Scholar
  18. 18.
    G. L. Buraggi, L. Callegaro, A. Turrin, E. Bombardieri, L. Gennari, G. Mariani, E. Regalia, R. Doci, M. Gasparini, E. Seregni, Radioimmunodetection of colorectal carcinoma with an anti-CEA monoclonal antibody, Proc. European Nuclear Medicine Congress, London, 1985 (in press).Google Scholar
  19. 19.
    P. Salacinski, J. Hope, C. McLean, Iodination of proteins, glycoproteins and peptides using a solid phase oxidizing agent (IODO GEN), Anal. Biochem. 117:136 (1981).PubMedCrossRefGoogle Scholar
  20. 20.
    D. J. Hnatowich, W. W. Layne, R. L. Childs, The preparation and labelling of DTPA-coupled albumin, Int. J. Appl. Radiat. Isot. 33:327 (1982).PubMedCrossRefGoogle Scholar
  21. 21.
    L. Callegaro, S. Ferrone, G. Plassio, M. Dovis, G. Mariani, G. L. Buraggi, A. Boniolo, U. Rosa, Biochemical characterization of monoclonal antibodies and F(ab’)2 fragments against human melanoma associated antigens labelled with different radioactive isotopes, J. Nucl. Med. All. Sci. 27:82 (1983).Google Scholar
  22. 22.
    W. S. Snyder, M. R. Ford, G. G. Warner, S. B. Watson, “S” absorbed dose per unit cumulated activity for selected radionuclides and organs, in: “MIRD Pamphlet No. II,” Society of Nuclear Medicine, New York (1975).Google Scholar
  23. 23.
    G. L. Buraggi, A. Turrin, N. Cascinelli, A. Attili, M. Gasparini, L. Callegaro, S. Ferrone, E. Seregni, E. Bombardieri, F. Belli, Radioimmunodetection of melanoma: preliminary results of a prospective study, Int. J. Biol. Markers 1:47 (1986).PubMedGoogle Scholar
  24. 24.
    A. G. Siccardi, G. L. Buraggi, L. Callegaro, G. Mariani, P. G. Natali, A. Abbati, M. Bestagno, V. Caputo, G. Galli, R. Masi, G. Paganelli, P. Riva, M. Salvatore, M. Sanguineti, G. L. Turco, G. A. Scassellati, S. Ferrone, “A Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma,” Cancer Res., 46:4817 (1986).PubMedGoogle Scholar
  25. 25.
    S. M. Larson, J. A. Carrasquillo, J. C. Reynolds, Radioimmunodetection and radioimmunotherapy, Cancer Invest. 2:363 (1984).PubMedCrossRefGoogle Scholar
  26. 26.
    S. M. Larson, Radiolabelled monoclonal antitumor antibodies in diagnosis and therapy, J. Nucl. Med. 26:538 (1985).PubMedGoogle Scholar
  27. 27.
    D. Colcher, M. Zalutsky, W. Kaplan, D. Kuffe, F. Austin, J. Schlom, Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody, Cancer Res. 43:736 (1983).PubMedGoogle Scholar
  28. 28.
    J. F. Chatal, J. C. Saccavini, P. Fumoleau, J. Y. Douillard, C. Curtel, M. Kremer, B. LeMevel, H. Koprowski, Immunoscintigraphy of colon carcinoma, J. Nucl. Med. 25:307 (1984).PubMedGoogle Scholar
  29. 29.
    J. P. Mach, J. F. Chatal, J. D. Lumbroso, F. Buchegger, M. Forni, J. Ritschard, C. Berche, J. Y. Douillard, S. Carrel, M. Herlyn, Z. Steplewski, H. Koprowski, Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma, Cancer Res. 43:5593 (1983).PubMedGoogle Scholar
  30. 30.
    A. A. Epenetos, K. E. Britton, S. Mather, J. Shepherd, M. Granowska, J. Taylor-Papadimitriou, C. C. Nimmon, H. Durbin, L. R. Hawkins, J. S. Malpes, W. F. Bodmer, Targeting of iodine-123-labeled tumor-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumors, Lancet ii:999 (1982).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Gian Luigi Buraggi
    • 1
  1. 1.Nuclear Medicine DivisionNational Cancer InstituteMilanoItaly

Personalised recommendations